The significance of a single episode of minimal acute rejection after lung transplantation

被引:132
|
作者
Hachem, RR
Khalifah, AP
Chakinala, MM
Yusen, RD
Aloush, AA
Mohanakumar, T
Patterson, GA
Trulock, EP
Walter, MJ
机构
[1] Washington Univ, Sch Med, Div Pulm & Crit Care, St Louis, MO 63110 USA
[2] Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX 75230 USA
[3] Washington Univ, Sch Med, Div Cardiothorac Surg, St Louis, MO 63110 USA
关键词
lung transplantation; minimal acute rejection; bronchiolitis obliterans syndrome;
D O I
10.1097/01.tp.0000181161.60638.fa
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Bronchiolitis obliterans syndrome (BOS) remains the leading obstacle to better long-term outcomes after lung transplantation. Acute rejection has been identified as the primary risk factor for BOS, but the impact of minimal acute rejection, especially a solitary episode, has usually been discounted as clinically insignificant. Methods. We performed a retrospective cohort study of 259 adult lung transplant recipients to determine the risk of BOS associated with a single episode of A1 rejection, without recurrence or subsequent progression to a higher grade. The cohort was divided into 3 groups based on the severity of acute rejection (none, single episode of A1, and single episode of A2). We determined the risks of BOS stages 1, 2, 3, and death for each group using univariate and multivariate Cox regression analyses. Results. A solitary episode of At rejection was a significant risk factor for BOS stages I and 2, but not stage 3 or death, in the univariate analysis. Multivariate Cox regression models confirmed that the risk of BOS attributable to a single episode of A1 rejection was independent of other potential risk factors, such as community acquired respiratory viral infections, number of HLA mismatches, and cytomegalovirus pneumonitis. Likewise, univariate and multivariate analyses demonstrated that a single episode of A2 rejection was a significant risk factor for all stages of BOS but not death. Conclusions. A single episode of minimal acute rejection without recurrence or subsequent progression to a higher grade is a significant predictor of BOS independent of other risk factors.
引用
收藏
页码:1406 / 1413
页数:8
相关论文
共 50 条
  • [21] Everolimus's Influence on Persistent Acute Rejection After Experimental Lung Transplantation
    Brunner, Elisabeth
    Lehle, Karla
    Hirt, Stephan W.
    Schmid, Christof
    von Suesskind-Schwendi, Marietta
    ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2013, 22 (03): : 355 - 359
  • [22] The role of interleukin-17 during acute rejection after lung transplantation
    Vanaudenaerde, BM
    Dupont, LJ
    Wuyts, WA
    Verbeken, E
    Meyts, I
    Bullens, DM
    Dilissen, E
    Luyts, L
    Van Raemdonck, DE
    Verleden, GM
    EUROPEAN RESPIRATORY JOURNAL, 2006, 27 (04) : 779 - 787
  • [23] Cytokine levels in pleural fluid as markers of acute rejection after lung transplantation
    Leon Bueno de Camargo, Priscila Cilene
    Afonso, Jose Eduardo, Jr.
    Samano, Marcos Naoyuki
    Pagliarelli Acencio, Milena Marques
    Antonangelo, Leila
    de Oliveira Braga Teixeira, Ricardo Henrique
    JORNAL BRASILEIRO DE PNEUMOLOGIA, 2014, 40 (04) : 425 - 428
  • [24] Acute rejection after lung transplantation: association between histopathological and CT findings
    Ambra Di Piazza
    Giuseppe Mamone
    Settimo Caruso
    Gianluca Marrone
    Fabio Tuzzolino
    Patrizio Vitulo
    Alessandro Bertani
    Roberto Miraglia
    La radiologia medica, 2019, 124 : 1000 - 1005
  • [25] Recurrent treatment of refractory acute cellular rejection with alemtuzumab after lung transplantation
    van Haren, Eva
    van Vugt, Lukas K.
    Wijbenga, Nynke
    van der Sijs, Heleen
    Hellemons, Merel E.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2024, 43 (11) : 1864 - 1868
  • [26] Minimal acute cellular rejection remains prevalent up to 2 years after lung transplantation: A retrospective analysis of 2697 transbronchial biopsies
    Burton, Christopher M.
    Iversen, Martin
    Scheike, Thomas
    Carlsen, Jorn
    Andersen, Claus B.
    TRANSPLANTATION, 2008, 85 (04) : 547 - 553
  • [27] Management of chronic rejection after lung transplantation
    Bedair, Bahaa
    Hachem, Ramsey R.
    JOURNAL OF THORACIC DISEASE, 2021, 13 (11) : 6645 - 6653
  • [28] Mechanisms of graft rejection after lung transplantation
    Hsiao, Hsi-Min
    Scozzi, Davide
    Gauthier, Jason M.
    Kreisel, Daniel
    CURRENT OPINION IN ORGAN TRANSPLANTATION, 2017, 22 (01) : 29 - 35
  • [29] Prevention of chronic rejection after lung transplantation
    Van Herck, Anke
    Verleden, Stijn E.
    Vanaudenaerde, Bart M.
    Verleden, Geert M.
    Vos, Robin
    JOURNAL OF THORACIC DISEASE, 2017, 9 (12) : 5472 - 5488
  • [30] Tacrolimus exposure early after lung transplantation and exploratory associations with acute cellular rejection
    David R. Darley
    Lilibeth Carlos
    Stefanie Hennig
    Zhixin Liu
    Richard Day
    Allan R. Glanville
    European Journal of Clinical Pharmacology, 2019, 75 : 879 - 888